Insulin Glulisine (Apidra) from Germany
Ultra-rapid acting insulin analogue with glycine/lysine modifications at B-chain. HTS 2937.12.00.00 covers rDNA-produced structural analogues used primarily as polypeptide hormones.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Sequence analysis certificate confirming glulisine modifications essential
• Maintain refrigerated conditions; ultra-rapid analogues have narrow stability window
• API vs finished product distinction critical for correct HTS classification